Elizabeth A. Gasser - Jun 2, 2021 Form 3 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP, Chief Strategy Officer
Signature
s/ David B. Berger, Attorney-in-Fact for Elizabeth A. Gasser
Stock symbol
TNDM
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
3
Date filed
6/10/2021, 04:55 PM
Next filing
Aug 31, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNDM Common Stock 975 Jun 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNDM Stock Option Jun 2, 2021 Common Stock 38.2K $89.54 Direct F1, F2, F3
holding TNDM Stock Option Jun 2, 2021 Common Stock 13.8K $82.34 Direct F1, F3, F4
holding TNDM Restricted Stock Unit Jun 2, 2021 Common Stock 5.96K $0.00 Direct F1, F5
holding TNDM Stock Option Jun 2, 2021 Common Stock 7.94K $81.63 Direct F1, F3, F6
holding TNDM Restricted Stock Unit Jun 2, 2021 Common Stock 2.6K $0.00 Direct F1, F7
holding TNDM Performance Stock Unit Jun 2, 2021 Common Stock 2.6K $0.00 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 The date of grant of the option was 02/18/2020. 25% of the shares subject to the option vested on 02/18/2021 and the remainder vests in 36 equal monthly installments thereafter.
F3 The expiration date for these options is 10 years from the date of grant.
F4 The date of grant of the option was 05/27/2020. 25% of the shares subject to the option vested on 05/27/2021 and the remainder vests in 36 equal monthly installments thereafter.
F5 The date of Restricted Stock Unit ("RSU") grant was 05/27/2020. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F6 The date of grant of the option was 05/18/2021. 25% of the shares subject to the option will vest on 05/18/2022 and the remainder vests in 36 equal monthly installments thereafter.
F7 The date of Restricted Stock Unit ("RSU") grant was 05/18/2021. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 05/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F8 Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.